Japan’s 2.5% Population Drop Forces Life Insurers to Reprice Longevity and LTC

Japan’s 2025 census preliminary results confirm what actuaries have long feared: the country’s total population fell 2.5% between 2020 and 2025, to just over 123 million, recording the sharpest five-year census decline on record. As J-ICS — Japan’s new economic value-based solvency regime — entered force from March 31, 2026, life insurers now must mark longevity and interest-rate liabilities to market for the first time. The collision of demographic free-fall and regulatory overhaul is not a future risk: it is balance-sheet reality today.

A Census That Confirms Structural Demographic Collapse

The headline census figure barely captures the depth of the structural shift. According to the Japan Statistics Bureau, Japan’s total population as of October 1, 2024 stood at 123,802,000 — down 550,000 from the prior year, a rate of decline of 0.44%, marking the fourteenth consecutive year of decrease. Meanwhile, the population aged 65 and over reached 36,243,000, representing 29.3% of the total population — the highest old-age dependency ratio among major economies. At the other end of the age spectrum, those under 15 numbered only 13,830,000, or 11.2% of the population, a ratio that effectively locks in future premium-base erosion for decades.

Fertility data from the Ministry of Health, Labour and Welfare reinforces the alarm. Japan recorded only 686,061 births in 2024 — a record low for the ninth consecutive year and the first time the annual birth count has fallen below 700,000 since records began in 1899 — with the total fertility rate hitting a historic low of 1.15. The mortality side is equally stark: Japan’s natural population decrease reached a record 919,237 in 2024, as deaths climbed to a postwar high of 1,605,298 against only 686,061 births. When deaths outnumber births by nearly a million each year, no immigration flow realistically offsets the aggregate drag on working-age premium income.

The National Institute of Population and Social Security Research (IPSS) projects the trajectory will worsen materially: Japan’s 65+ share is expected to rise from 28.6% in 2020 to 38.7% by 2070, while the ratio of working-age persons per senior compresses from 2.1 to 1.3. For an insurer pricing a 30-year annuity today, those projections are not macro background — they are the central longevity assumption in the liability discount curve.

J-ICS Transforms a Known Risk into a Visible Capital Shock

Japan’s existing solvency framework, the Solvency Margin Ratio (SMR), has been a poor lens for longevity and interest-rate risk: its book-value accounting allowed mismatches between long-dated liabilities and shorter-duration assets to sit largely below the regulatory radar. The FSA’s capital adequacy framework set a hard floor: the SMR minimum threshold is 200%, below which prompt corrective action is triggered. But this threshold measured neither economic duration mismatch nor the longevity tail correctly.

J-ICS changes that. The new regime, developed by the FSA’s Advisory Council on Economic Value-based Solvency and modelled closely on the European Solvency II architecture, requires insurers to value both assets and liabilities at market-consistent economic value. As detailed in Milliman’s February 2026 analysis of the J-ICS framework, from the end of March 2026, solvency reporting by insurance companies in Japan must be based on this new regulation. For life insurers with decades-long in-force books of whole-life and annuity contracts, the first reporting cycle will crystallise longevity mismatches that the SMR regime allowed to remain latent.

This dynamic is directly relevant to the wave of consolidation already under way. PayPay’s acquisition of T&D Financial Life, Japan’s most-watched life sector deal of 2026, is partly a bet that scale provides capital efficiency under J-ICS — a smaller balance sheet cannot absorb the volatility that economic-value reporting will introduce each quarter. Regulators are watching closely, as the FSA’s ongoing scrutiny of Japanese life insurer conduct and capital practices demonstrates.

A $3 Trillion Longevity Reserve Pool With Barely 1% Reinsured

The reinsurance arithmetic is striking. According to Society of Actuaries research on the Japanese life market, Japan’s life insurance in-force liabilities and annuity reserves total approximately $3 trillion; as of Q3 2024, only three of the top 10 life insurers had engaged in asset-intensive block reinsurance, representing less than 1% of reserves. In the United Kingdom — the reference market for longevity transfer — the bulk annuity and longevity swap market has been absorbing tens of billions annually; Canada Life’s recent bulk annuity buy-in illustrates how insurers in mature markets are accelerating longevity de-risking as rates stabilise. Japan has yet to reach that inflection point, but J-ICS is the regulatory catalyst that could compress a decade of market development into three to five years.

The demand signal is already attracting capacity. Swiss Re’s appointment of a dedicated head for L&H transactions as its longevity pipeline builds is one visible indicator. Global reinsurers — Swiss Re, Munich Re, RGA, Hannover Re — have all flagged APAC longevity as a growth vector, but converting pipeline into executed transactions requires cedants to reach a pricing and governance threshold. J-ICS forces that threshold earlier than many Japanese management teams had planned.

With the working-age population (15–64) already at 73,728,000 — just 59.6% of the total — and male natural population change negative for twenty consecutive years and female for sixteen, the pace of reserve accretion on existing LTC and annuity books will continue to outpace new premium income from the shrinking active workforce. This is not a slow-burn risk: the demographic pipeline is closed.

Who Bears the Cost — and How the Market Adjusts

The J-ICS disclosure cycle will clarify the distribution of longevity risk across four sets of counterparties. First, cedants: primary life insurers whose capital ratios decline under economic-value reporting will face pressure from the FSA and boards to transfer longevity tail risk — accelerating demand for block reinsurance and longevity swaps. Second, reinsurers: those with appetite and Japanese regulatory authorisation stand to capture a structurally undersupplied market; the constraint is not demand but pricing consensus and collateral structures suited to yen-denominated books. Third, policyholders: product repricing is already visible in reduced guaranteed annuity rates and tighter LTC benefit triggers for new business. Fourth, the state: Japan’s public long-term care insurance system, established in 2000, absorbs a portion of the demographic cost, but its own fiscal sustainability is under strain as the support ratio compresses toward the IPSS projection of 1.3 workers per senior by 2070.

The structural answer is market deepening — not just reinsurance, but longevity indices, standardised swap documentation in Japanese regulatory formats, and domestic capital market solutions. Japan’s Ministry of Finance and the FSA have signalled awareness of the gap. Whether the market infrastructure develops fast enough to absorb the actuarial clock’s cadence remains the open question as the first J-ICS reporting cycle closes.

Mini-FAQ

Sources used

• Japan Statistics Bureau — Population Estimates 2024 (Ministry of Internal Affairs and Communications)
• Ministry of Health, Labour and Welfare — Vital Statistics 2024
• Japan Financial Services Agency — Insurance Capital Adequacy (Solvency Margin Ratio)
• Japan FSA — Advisory Council on Economic Value-based Solvency (J-ICS)
• IPSS — National Population Projections for Japan (2023 revision)
• Milliman — ESR/J-ICS Life Insurance Solvency Regulation in Japan (February 2026)
• Society of Actuaries Reinsurance Section Newsletter — Japan Life In-force Block Reinsurance (December 2024)